share_log

Eros Receives NYSE Extension Through Aug. 17, 2022 For Annual Report Filing

Eros Receives NYSE Extension Through Aug. 17, 2022 For Annual Report Filing

Eros收到紐約證交所延長至2022年8月17日的年度報告備案
Benzinga Real-time News ·  2022/08/04 06:00

Eros Media World Plc (NYSE:EMWP) ("Eros", the "Company") today announced that the New York Stock Exchange (the "NYSE") has granted the Company an extension through August 17, 2022, subject to reassessment on an ongoing basis, to complete and file with the Securities and Exchange Commission its annual report on Form 20-F for the fiscal year ended March 31, 2021 (the "2021 20-F") and the Company's Semi-Annual Report on Form 6-K for the six months ended September 30, 2021 including the unaudited financial statements to be contained therein (the "2022 HY 6-K").

Eros Media World Plc(紐約證券交易所股票代碼:EMWP)(以下簡稱“Eros”,以下簡稱“公司”)今天宣佈,紐約證券交易所(以下簡稱“紐約證券交易所”)已批准該公司延期至2022年8月17日,但需持續進行重新評估,以完成其截至2021年3月31日的財政年度的Form 20-F年度報告(以下簡稱“2021年20-F報告”)和公司截至9月30日的6個月的Form 6-K半年度報告。2021年,包括將包含的未經審計的財務報表(“2022年HY 6-K”)。

The NYSE has notified the Company that it will closely monitor the Company's progress with the interim milestones the Company previously submitted to the NYSE and that failure to achieve these interim milestones could potentially result in an accelerated trading suspension prior to August 17, 2022.

紐約證券交易所已經通知該公司,它將密切關注公司之前向紐約證券交易所提交的中期里程碑的進展情況,如果不能實現這些中期里程碑,可能會導致在2022年8月17日之前加速停牌。

In addition, in the event that the Company does not complete its Delayed Filings and any subsequent delayed filings with the SEC by the end of the maximum 12-month cure period on August 17, 2022, the NYSE will move forward with the initiation of suspension and delisting procedures. NYSE will also continue to monitor the Company's progress on its other delayed filings as part of continued listing assessment, and will maintain the "LF" indicator on the Company's securities and include the Company on the "late filer" list on  until such time as the Company is current with all of its periodic SEC filings.

此外,如果該公司在2022年8月17日最長12個月的治療期結束前仍未完成其延遲向美國證券交易委員會提交的文件,紐約證券交易所將啟動停牌和退市程序。作為持續上市評估的一部分,紐約證券交易所還將繼續監測該公司在其他延遲提交文件方面的進展,並將維持該公司證券的“LF”指標,並將該公司列入“遲交文件”名單,直到該公司與其所有定期美國證券交易委員會文件保持同步。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論